Organism |
Reference |
---|
Escherichia coli K1 | K1 |
651736 |
Neisseria meningitidis | MC58 group B |
661102 |
Staphylococcus aureus | MRSA |
755205 |
Staphylococcus aureus COL | MRSA |
755205 |
Staphylococcus epidermidis | MRSE |
755205 |
Staphylococcus epidermidis CLB26329 | MRSE |
755205 |
Staphylococcus aureus | MSRA strain |
726555 |
Homo sapiens | mutations in patients with hereditary inclusion body myopathy: G135V/R246W (GNE/GNE domain mutation), UDP-N-acetylglucosamine 2-epimerase activity is 38% of wild-type, N-acetylmannosamine kinase activity is 72% of wild-type. V216A/A631V (GNE/MNK domain mutation), UDP-N-acetylglucosamine 2-epimerase activity is 48% of wild-type, N-acetylmannosamine kinase activity is 63% of wild-type. M712T/M712T (MNK/MNK domain mutation), UDP-N-acetylglucosamine 2-epimerase activity is 83% of wild-type, N-acetylmannosamine kinase activity is 55% of wild-type |
661840 |
Homo sapiens | three different isozymes, hGNE1, hGNE2, and hGNE3, from the two splice variants including exon A1, The N-terminus of hGNE2 is prolonged by 31 additional amino acids. The lack of exon 2 in the cDNA encoding for hGNE3 leads to loss of the first 55 amino acids of hGNE1 |
702507 |